Beta‐amyloid interacts with and activates the long‐form phosphodiesterase PDE4D5 in neuronal cells to reduce cAMP availability
FEBS Letters · 2024
DOI: 10.1002/1873-3468.14902 ↗Kurz gefasst
Fachartikel in der Zeitschrift FEBS Letters, 2024. Verfasst von Yuan Yan Sin und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Cardiovascular and Metabolic Health, University of Glasgow, UK. Hauptthemen laut MEDLINE: Amyloid beta-Protein Precursor, Cyclic AMP, Cyclic Nucleotide Phosphodiesterases, Type 4, Neurons. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council.
Abstract (Originalsprache)
Inhibition of the cyclic‐AMP degrading enzyme phosphodiesterase type 4 (PDE4) in the brains of animal models is protective in Alzheimer's disease (AD). We show for the first time that enzymes from the subfamily PDE4D not only colocalize with beta‐amyloid (Aβ) plaques in a mouse model of AD but that Aβ directly associates with the catalytic machinery of the enzyme. Peptide mapping suggests that PDE4D is the preferential PDE4 subfamily for Aβ as it possesses a unique binding site. Intriguingly, exogenous addition of Aβ to cells overexpressing the PDE4D5 longform caused PDE4 activation and a decrease in cAMP. We suggest a novel mechanism where PDE4 longforms can be activated by Aβ, resulting in the attenuation of cAMP signalling to promote loss of cognitive function in AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Cardiovascular and Metabolic Health, University of Glasgow, UK.
- Department of Neuroscience, Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium.
- Department Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, The Netherlands.
ORCID-Profile: Tom A Wright, George S Baillie
Förderung
- Biotechnology and Biological Sciences Research Council
Zitieren
APA
Sin, Y. Y., Cameron, R. T., Schepers, M., MacLeod, R., Wright, T. A., Paes, D., van den Hove, D., Willems, E., Vanmierlo, T., Prickaerts, J., Blair, C. M., & Baillie, G. S. (2024). Beta‐amyloid interacts with and activates the long‐form phosphodiesterase PDE4D5 in neuronal cells to reduce cAMP availability. FEBS Letters. https://doi.org/10.1002/1873-3468.14902
Vancouver
Sin YY, Cameron RT, Schepers M, MacLeod R, Wright TA, Paes D, et al. Beta‐amyloid interacts with and activates the long‐form phosphodiesterase PDE4D5 in neuronal cells to reduce cAMP availability. FEBS Letters. 2024. doi:10.1002/1873-3468.14902
BibTeX
@article{Sin2024,
author = {Sin, Yuan Yan and Cameron, Ryan T and Schepers, Melissa and MacLeod, Ruth and Wright, Tom A and Paes, Dean and van den Hove, Daniel and Willems, Emily and Vanmierlo, Tim and Prickaerts, Jos and Blair, Connor M and Baillie, George S},
title = {Beta‐amyloid interacts with and activates the long‐form phosphodiesterase PDE4D5 in neuronal cells to reduce cAMP availability},
journal = {FEBS Letters},
year = {2024},
doi = {10.1002/1873-3468.14902}
}
EUVIMED